GSK-3α siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(2) Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 ActivityInternational journal of molecular sciencesOctober 14, 2021Łasut-Szyszka B, Małachowska B, Gdowicz-Kłosok A, Krześniak M, Głowala-Kosińska M, Zajkowicz A, Rusin M.with control lentiviruses). The lentiviruses were purchased from Santa Cruz Biotechnology (cat no. sc-29339 for anti-GSK3A lentivirus and no. sc-108080 for control lentivirus). The procedure was performed according

(4) Antagonistic role of GSK3 isoforms in glioma survivalJournal of CancerJanuary 1, 2018Vashishtha V, Jinghan N, K Yadav A.

(5) Progesterone in Breast Cancer AngiogenesisSM journal of reproductive health & infertilityJanuary 1, 2015Botelho MC, Soares R, Alves H.

(7) Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancerOncoTargets and therapyJanuary 1, 2014Fu Y, Wang X, Cheng X, Ye F, Xie X, Lu W.experiments. RNA interference Small interfering RNA (siRNA) specific to human GSK3α (GSK-3α siRNA [h] sc-29339) and GSK3β (GSK-3β siRNA [h] sc-35527) were purchased from Santa Cruz Biotechnology. Unrelated control

GSK-3α siRNA (h)